New RNA therapies for treatment of ASCVD, Prevention and Dyslipidemia

New RNA Therapies for Treatment of ASCVD, Prevention, and Dyslipidemia

Guest: R. Scott Wright, M.D.
Host: Stephen L. Kopecky, M.D.

RNA therapies are growing in number as targeted treatments for dyslipidemia including LDL-c, Lp(a) and Triglycerides. The podcast will explore the science behind these therapies, the evidence for safety and how clinicians can utilize them in their practices. 

Topics Discussed:

• What are the new RNA therapies available or soon to be available?
• How are RNA based therapies being used?
• How do they compare to the COVID-19 vaccine?
• What is their effectiveness and side effect profile?
• Are there side effects or concerns?

Length: 00:00:00